Primary splenic B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A case report

Shi,Feng; Zhou,Quan; Gao,Ying; Cui,Xiang‑Qing; Chang,Hong

doi:10.3892/ol.2016.4840

Primary splenic B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A case report

Authors:
- Feng Shi
- Quan Zhou
- Ying Gao
- Xiang‑Qing Cui
- Hong Chang
View Affiliations

Affiliations: Department of Pathology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, P.R. China, Department of Pathology, Pu Ren Hospital, Beijing 100062, P.R. China
Published online on: July 11, 2016 https://doi.org/10.3892/ol.2016.4840
Pages: 1925-1928

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

B-cell lymphoma (BCL), unclassifiable, with features intermediate between diffuse large BCL (DLBCL) and classical Hodgkin's lymphoma (CHL), is a novel entity to the World Health Organization classification system. These tumors are rare aggressive lymphomas that have a poor prognosis. The present study reports the case of a patient with one such lymphoma that occurred in the spleen, which expressed cluster of differentiation (CD)20, CD79α, melanoma associated antigen (mutated) 1, BCL6, CD15 and CD30. Polymerase chain reaction analysis demonstrated a clonal rearrangement of the genes coding for immunoglobulin heavy chains. The tumor cells demonstrated a negative reaction in the Epstein-Barr virus-encoded small RNA assay. Following the diagnosis of unclassifiable BCL, with intermediate features between DLBCL and CHL, the patient received 7 cycles of the CHOP regimen, and so far, has been in good general condition and tumor-free for 17 months.

View Figures

View References

1	Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J and Vardiman JW: WHO classification of tumours. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 2:(4th). IARC Press. (Lyon). 267–268. 2008.
2	Iriyama N, Horikoshi A, Hatta Y, Kobayashi Y, Sawada S and Takeuchi J: Localized, splenic, diffuse large B-cell lymphoma presenting with hypersplenism: Risk and benefit of splenectomy. Inter Med. 49:1027–1030. 2010. View Article : Google Scholar
3	Kurup SK, Levy-Clarke G, Calvo KR, Jaffe ES, Nussenblatt RB and Chan CC: Primary diffuse large B-cell lymphoma of the spleen with coincident serous retinal detachments responsive to corticosteroids. Clin Experiment Ophthalmol. 35:468–472. 2007. View Article : Google Scholar : PubMed/NCBI
4	Ding YL and Wang SY: Gastrosplenic fistula due to splenic large B-cell lymphoma. J Res Med Sci. 17:805–807. 2012.PubMed/NCBI
5	Matutes E: Splenic marginal zone lymphoma: Disease features and management. Expert Rev Hematol. 6:735–745. 2013. View Article : Google Scholar : PubMed/NCBI
6	Asano N, Suzuki R, Matsuo K, Kagami Y, Ishida F, Tamaru JI, Jin GS, Sato Y, Shimoyama Y, Yoshino T, et al: Cytotoxic molecule expression is predictive of prognosis in Hodgkin's-like anaplastic large cell lymphoma. Histopathology. 50:705–715. 2007. View Article : Google Scholar : PubMed/NCBI
7	Kim JK, Hahn JS, Kim GE and Yang WI: Three cases of diffuse large B-cell lymphoma presenting as primary splenic lymphoma. Yonsei Med J. 46:703–709. 2005. View Article : Google Scholar : PubMed/NCBI
8	Gardner RV, Velez MC, Ode DL, Lee JW and Correa H: Gamma/delta T-cell lymphoma as a recurrent complication after transplantation. Leuk Lymphoma. 45:2355–2359. 2004. View Article : Google Scholar : PubMed/NCBI
9	Travers-Glehen A, Pittaluga S, Gaulard P, Sorbara L, Alonso MA, Raffeld M and Jaffe ES: Mediastinal gray zone lymphoma: The missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma. Am J Surg Pathol. 29:1411–1421. 2005. View Article : Google Scholar : PubMed/NCBI
10	Rüdiger T, Jaffe ES, Delsol G, deWolf-Peeters C, Gascoyne RD, Georgii A, Harris NL, Kadin ME, MacLennan KA, Poppema S, et al: Workshop report on Hodgkin's disease and related diseases (‘gray zone’ lymphoma). Ann Oncol. 9(Suppl 5): S31–S38. 1998. View Article : Google Scholar
11	Portlock CS, Donnelly GB, Qin J, Straus D, Yahalom J, Zelenetz A, Noy A, O'Connor O, Horwitz S, Moskowitz C and Filippa DA: Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin's disease. Br J Haematol. 125:701–708. 2004. View Article : Google Scholar : PubMed/NCBI
12	Tzankov A, Krugmann J, Fend F, Fischhofer M, Greil R and Dirnhofer S: Prognostic significance of CD20 expression in classical Hodgkin lymphoma: A clinicopanthological study of 119 cases. Clin Cancer Res. 9:1381–1386. 2003.PubMed/NCBI
13	Grant C, Dunleavy K, Eberle FC, Pittaluga S, Wilson WH and Jaffe ES: Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: What is the oncologist to do? Curr Hematol Malig Rep. 6:157–163. 2011. View Article : Google Scholar : PubMed/NCBI
14	Dunleavy K, Grant C, Eberle FC, Pittaluga S, Jaffe ES and Wilson WH: Gray zone lymphoma: Better treated like Hodgkin lymphoma or mediastinal large B-cell lymphoma? Curr Hematol Malig Rep. 7:241–247. 2012. View Article : Google Scholar : PubMed/NCBI
15	Parikh JG, Strom T and Stone I: MYC negative rectal B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt's lymphoma in an immunocompetent patient. Case Rep Pathol. 2013:3023042013.PubMed/NCBI
16	Wang L, Wang W, Li X, Guo Y and Zhu X: Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: Clinicopathologic characterization of 16 cases showing different patterns. Zhonghua Bing Li Xue Za Zhi. 43:307–312. 2014.(In Chinese). PubMed/NCBI